Business

Bristol Myers to buy heart drug developer MyoKardia for about $13 billion

(Reuters) – Bristol Myers Squibb Co BMY.N said on Monday it would buy MyoKardia Inc MYOK.O for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs.The logo of U.S. drugmaker Bristol Myers Squibb. via REUTERS The deal follows Bristol Myers’ $74 […]

Business

Bristol Myers lifts annual profit view on hopes of pickup in patient visits

(Reuters) – Bristol Myers Squibb Co (BMY.N) raised its annual profit forecast on Thursday on hopes of a recovery in sales of its hospital-administered drugs, which had taken a hit as patients stayed away from doctors’ offices due to the COVID-19 pandemic. The U.S. drugmaker said it was expecting demand for its drugs from new […]